Max Healthcare is India’s second-largest hospital chain, but its P/E of 95 makes it look more like a unicorn startup than a healthcare company. With ₹2,028 Cr revenue and ₹308 Cr PAT this quarter, it’s a hospital chain that heals patients but gives investors chest pain with valuations.
2. Introduction
Hospitals are supposed to save lives, not burn cash. But in India, hospitals also double as luxury hotels with ventilators. Max Healthcare has 22 hospitals, 5,000 beds, and is on an acquisition spree — buying Jaypee, Alexis, Sahara, and every other hospital with a “For Sale” board.
Operating metrics? Decent. ARPOB at ₹77,000, occupancy 77%, and EBITDA per bed ₹71 lakh. Basically, every bed generates more revenue than a 2BHK flat in Lucknow.
But auditors don’t sleep peacefully. Debt jumped from ₹913 Cr in FY22 to ₹3,010 Cr in FY25. Expansions worth ₹5,300 Cr planned till FY28. It’s like Max is on a bed-adding marathon — 3,600 more by FY28, and then another 2,900 beyond FY29. Hospitals everywhere, ROE be damned.
3. Business Model – WTF Do They Even Do?
Max Healthcare’s business is a three-course meal:
Max Hospitals (core) – Surgeries, transplants, cancer care, ICUs, diagnostics, radiology. Everything from heart bypass to “sir, you just need rest.”
Max@Home – Lab tests, medicines, dialysis, physiotherapy delivered to your drawing room. Basically Swiggy for healthcare.
Max Lab – 1,150+ collection partners, because Indians love preventive checkups even more than they love WhatsApp forwards.
And then there’s the international referral business — patient centers in Kenya, Nigeria, UAE, and beyond. Essentially, Max imports patients like IT firms import coders.
4. Financials Overview
Metric
Latest Qtr (Q1 FY26)
YoY Qtr (Q1 FY25)
Prev Qtr (Q4 FY25)
YoY %
QoQ %
Revenue
2,028
1,543
1,910
31.4%
6.2%
EBITDA
523
387
512
35.2%
2.1%
PAT
308
236
319
30.4%
-3.4%
EPS (₹)
3.17
2.43
3.28
30.5%
-3.4%
Comment: Annualised EPS = ₹12.7. CMP ₹1,178 → P/E ~93x. Apollo at 72x looks cheap in comparison.
